Late endocrine, metabolic and skeletal sequelae following treatment of childhood cancer.

2.50
Hdl Handle:
http://hdl.handle.net/10541/81143
Title:
Late endocrine, metabolic and skeletal sequelae following treatment of childhood cancer.
Authors:
Gleeson, Helena K; Darzy, Ken H; Shalet, Stephen M
Abstract:
With an ever increasing adult population of childhood cancer survivors there is a need to focus on the late effects of cancer therapy. It is essential that, after discharge from the paediatric oncologists, the patients are not lost from the health system but are under continued surveillance with access to the appropriate physicians. Endocrine and metabolic consequences may affect a patient's life both soon after cancer treatment and also for many years in the future. In this review we consider the following potential problems: growth hormone deficiency and replacement in adulthood, cardiovascular risk factors, osteopaenia, thyroid and parathyroid dysfunction.
Affiliation:
Department of Endocrinology, Christie Hospital, Wilmslow Road, Manchester, Withington, M20 4BX, UK.
Citation:
Late endocrine, metabolic and skeletal sequelae following treatment of childhood cancer. 2002, 16 (2):335-48 Best Pract. Res. Clin. Endocrinol. Metab.
Journal:
Best Practice & Research. Clinical Endocrinology & Metabolism
Issue Date:
Jun-2002
URI:
http://hdl.handle.net/10541/81143
DOI:
10.1053/beem.2002.0201
PubMed ID:
12064896
Type:
Article
Language:
en
ISSN:
1521-690X
Appears in Collections:
All Christie Publications

Full metadata record

DC FieldValue Language
dc.contributor.authorGleeson, Helena K-
dc.contributor.authorDarzy, Ken H-
dc.contributor.authorShalet, Stephen M-
dc.date.accessioned2009-09-15T15:59:24Z-
dc.date.available2009-09-15T15:59:24Z-
dc.date.issued2002-06-
dc.identifier.citationLate endocrine, metabolic and skeletal sequelae following treatment of childhood cancer. 2002, 16 (2):335-48 Best Pract. Res. Clin. Endocrinol. Metab.en
dc.identifier.issn1521-690X-
dc.identifier.pmid12064896-
dc.identifier.doi10.1053/beem.2002.0201-
dc.identifier.urihttp://hdl.handle.net/10541/81143-
dc.description.abstractWith an ever increasing adult population of childhood cancer survivors there is a need to focus on the late effects of cancer therapy. It is essential that, after discharge from the paediatric oncologists, the patients are not lost from the health system but are under continued surveillance with access to the appropriate physicians. Endocrine and metabolic consequences may affect a patient's life both soon after cancer treatment and also for many years in the future. In this review we consider the following potential problems: growth hormone deficiency and replacement in adulthood, cardiovascular risk factors, osteopaenia, thyroid and parathyroid dysfunction.en
dc.language.isoenen
dc.subjectCanceren
dc.subject.meshAntineoplastic Agents-
dc.subject.meshBone Diseases-
dc.subject.meshCardiovascular Diseases-
dc.subject.meshChild-
dc.subject.meshEndocrine System Diseases-
dc.subject.meshGonadal Steroid Hormones-
dc.subject.meshHuman Growth Hormone-
dc.subject.meshHumans-
dc.subject.meshNeoplasms-
dc.subject.meshRadiotherapy-
dc.subject.meshThyroid Diseases-
dc.titleLate endocrine, metabolic and skeletal sequelae following treatment of childhood cancer.en
dc.typeArticleen
dc.contributor.departmentDepartment of Endocrinology, Christie Hospital, Wilmslow Road, Manchester, Withington, M20 4BX, UK.en
dc.identifier.journalBest Practice & Research. Clinical Endocrinology & Metabolismen

Related articles on PubMed

All Items in Christie are protected by copyright, with all rights reserved, unless otherwise indicated.